scholarly article | Q13442814 |
P2093 | author name string | Cosgrove LJ | |
Elleman TC | |||
McKern NM | |||
Ward CW | |||
Frenkel MJ | |||
Garrett TP | |||
Ivancic N | |||
Lou M | |||
Bentley JD | |||
Lovrecz GO | |||
Verkuylen A | |||
P2860 | cites work | axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase | Q24310364 |
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product | Q27860841 | ||
All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor | Q28626012 | ||
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains | Q33392787 | ||
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity | Q33880454 | ||
Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity | Q36765148 | ||
Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants | Q38322445 | ||
The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras | Q38338637 | ||
The science of macromolecular crystallization | Q40427597 | ||
Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding | Q41098705 | ||
Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis | Q41368833 | ||
Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor | Q41428446 | ||
Identification of a disulfide bridge connecting the alpha-subunits of the extracellular domain of the insulin receptor | Q41589386 | ||
Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors | Q41661260 | ||
Changing the insulin receptor to possess insulin-like growth factor I ligand specificity | Q41725096 | ||
A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity | Q42070889 | ||
A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. | Q42809660 | ||
Structural organization of the human insulin receptor ectodomain. | Q52409983 | ||
On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. | Q52464078 | ||
Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2 | Q56915399 | ||
Interactions of a hybrid insulin/insulin-like growth factor-I analog with chimeric insulin/type I insulin-like growth factor receptors | Q70550599 | ||
Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit | Q70937602 | ||
Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture | Q71363680 | ||
Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor | Q71763596 | ||
Crystallization of a deglycosylated T cell receptor (TCR) complexed with an anti-TCR Fab fragment | Q71903483 | ||
Protein microheterogeneity and crystal habits: the case of epidermal growth factor receptor isoforms as isolated in a multicompartment electrolyzer with isoelectric membranes | Q72783765 | ||
The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain | Q73876950 | ||
P433 | issue | 12 | |
P921 | main subject | preproinsulin | Q7240673 |
P304 | page(s) | 2663-2666 | |
P577 | publication date | 1997-12-01 | |
P1433 | published in | Protein Science | Q7251445 |
P1476 | title | Crystallization of the first three domains of the human insulin-like growth factor-1 receptor | |
P478 | volume | 6 |
Q77779611 | A third fibronectin type III domain in the extracellular region of the insulin receptor family |
Q41789322 | Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer. |
Q33408460 | Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo |
Q40947522 | Congenital insulin resistance associated with a conformational alteration in a conserved beta-sheet in the insulin receptor L1 domain |
Q27764901 | Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor |
Q38335851 | Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. Minimizing ligand binding domain of the insulin receptor. |
Q30389131 | Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor |
Q30414571 | Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications |
Q41632332 | Structural studies of the detergent-solubilized and vesicle-reconstituted insulin receptor |
Q34944353 | The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity |
Q57793591 | The signalling conformation of the insulin receptor ectodomain |
Search more.